This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Vast majority of drugs prescribed in America are off-patent generics made in low...
Sweeping funding cuts threaten to undermine the innovation that has been a centr...
Novartis and Sanofi CEOs push for European benchmark against US prices
Pharmaceutical group says deal will help it establish leadership in treating rar...
Anglo-Swedish pharma company’s first-quarter earnings boosted by strong demand f...
Drugmaker says it can harness technology and change supply chain to guard agains...
A study co-authored by U.S. Food and Drug Administration scientists was released...
The U.S. Food and Drug Administration is providing an at-a-glance summary of new...
The U.S. Department of Health and Human Services and FDA today announced a serie...
The U.S. Food and Drug Administration today welcomed HHS Secretary Robert F. Ken...
Renowned surgeon-scientist and health policy expert, Martin A. Makary, M.D., M.P...
Today, the U.S. Food and Drug Administration approved a novel treatment for hemo...
The FDA granted marketing authorization of the first diagnostic test for chlamyd...
Under the leadership of HHS Secretary Robert F. Kennedy, Jr., the FDA is taking ...
London, UK -- 25 March 2025 -- GSK plc (LSE/NYSE: GSK) today announced that the ...
MONTREAL, March 25, 2025 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechn...
Melbourne Australia | 21 March 2025 -- Telix today announces that the United Sta...
Basel, March 20, 2025 – Novartis today announced that oral Fabhalta (iptacopan) ...
HORSHAM, Pa. (March 20, 2025) – Johnson & Johnson (NYSE: JNJ) today announced th...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Mar. 20, 2025-- Alnylam Pharmaceuticals, Inc....
On March 19, 2025, the Food and Drug Administration granted traditional approval...
TAMPA, FL, March 18, 2025 (GLOBE NEWSWIRE) -- Scienture Holdings, Inc. NASDAQ: S...
PRINCETON, N.J.--(BUSINESS WIRE) April 11, 2025 -- Bristol Myers Squibb (NYSE: ...